• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Drugs of today: Medicamentos de actualidad >A report from the 47th Annual Meeting of the American Society of Clinical Oncology (June 3-7, 2011 - Chicago, Illinois, USA).
【24h】

A report from the 47th Annual Meeting of the American Society of Clinical Oncology (June 3-7, 2011 - Chicago, Illinois, USA).

机译：美国临床肿瘤学会第47届年会的报告（2011年6月3日至7日，美国伊利诺伊州芝加哥）。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Improving survival, as well as the quality of life and functioning of survivors, is the main objective of cancer therapy, for which a very large number of drugs are currently available or under development as therapeutic candidates. Information on many of these compounds was discussed during the 2011 American Society of Clinical Oncology (ASCO) meeting in Chicago. The number of news presentations discussed during the meeting was incredibly high, with plenary, oral abstract, poster discussion and general poster sessions filling room upon room. The following report provides a quick review of major new research into drug and support therapies for cancer as presented at the meeting.
机译：改善生存率以及生存者的生活质量和功能是癌症治疗的主要目标，为此，目前有很多药物正在开发或正在开发中作为治疗候选药物。在2011年美国临床肿瘤学会（ASCO）在芝加哥举行的会议上讨论了有关这些化合物的信息。会议期间讨论的新闻报道数量之高令人难以置信，全体会议，口头摘要，海报讨论和一般性海报会议在各个房间中泛滥成灾。以下报告简要介绍了会议上介绍的有关癌症药物和支持疗法的重大新研究。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号